Search

everythinglearnresearchcommunity

for

Search:↓

Women with irregular periods and/or excessive body hair are more likely to have polycystic ovaries, and this condition is linked to higher health risks.

Myo-inositol may be more effective than metformin for inducing ovulation in women with PCOS.

Hirsute women with ovarian-sourced hirsutism are more likely to have irregular periods, with higher BMI and altered hormone ratios.

Severe menstrual issues in PCOS women signal higher risk for heart and metabolic problems.

Blood tests can detect ovarian Leydig cell tumors when scans don't, and surgery can confirm and treat these tumors.

Oral contraceptives can affect skin and hair, improve acne, but may cause pigmentation, dermatitis, and other conditions.

The conclusion is that removing both ovaries is the best treatment for excess male hormones in postmenopausal women, with medication as another option, and managing insulin resistance is important for diagnosis and treatment.

Ovarian hyperthecosis can cause symptoms even with normal testosterone levels, and surgery can improve these symptoms.

Polycystic ovary syndrome is a common hormonal disorder in women that affects health and fertility.

Elevated testosterone, DHEA-S, and FAI help identify PCOS risk in menstrual irregularities.

Women with PCOS often have different clinical signs, hormone levels, and gynecological issues compared to those without the condition.

Ovarian volume is significantly related to higher levels of certain hormones in Korean women with PCOS.

Ovarian stromal hyperplasia can cause high testosterone in postmenopausal women and is treated by removing the ovaries.

Acne severity in women with PCOS is significantly associated with their serum LH/FSH ratio.

The study successfully gathered a diverse group of 438 women to understand the prevalence of polycystic ovary syndrome, with most participants recruited online and at community fairs.

The TT/DHT ratio may help identify PCOS patients with severe metabolic issues.

Ultrasound measurement of the ovarian stroma to total area ratio is not a reliable single predictor of high male hormone levels in Thai women with PCOS, but works better when combined with clinical signs.

The treatment effectively reduced hair growth and was safe for patients with PCOS, but it needs better bleeding control.

Hyperandrogenism does not affect the quality of blastocysts in PCOS patients undergoing IVF.

Women with prediabetes may have a higher risk of PCOS-like changes, especially if they have impaired glucose tolerance.

Bariatric surgery improves ovulation rates in women with PCOS and obesity better than medical therapy.

Menstrual abnormalities in PCOS women may not greatly affect their metabolic and hormonal profile.

Lifestyle changes improve reproductive function and hormonal balance in obese women with PCOS.

Vitamin D may improve fertility in women with PCOS.

Women with PCOS are more likely to experience sexual dysfunction, but lifestyle changes and weight loss can improve sexual function.

Higher estrone-to-estradiol ratios are linked to worse glucose metabolism and insulin resistance in women with PCOS.

Hormonal dysfunctions, like PCOS, are common among reproductive-age women in India.

Laparoscopic ovarian drilling helps infertile women with PCOS by improving menstrual regularity, ovulation, and chances of conception, and by changing hormone levels.

Women with PCOS tend to be less optimistic than those without it.